Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia · Delayed Price · Currency is AUD 0.2600
-0.0100 (-3.70%)
Feb 5, 2026, 4:10 PM AEST
ASX:LDX Revenue
In the fiscal year ending June 30, 2025, Lumos Diagnostics Holdings had annual revenue of $12.40M USD with 11.40% growth. Lumos Diagnostics Holdings had revenue of $6.09M in the half year ending June 30, 2025, with 11.86% growth.
Revenue
$12.40M
Revenue Growth
+11.40%
P/S Ratio
10.89
Revenue / Employee
n/a
Employees
n/a
Market Cap
206.04M AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.40M | 1.27M | 11.40% |
| Jun 30, 2024 | 11.13M | 596.00K | 5.66% |
| Jun 30, 2023 | 10.54M | -1.10M | -9.42% |
| Jun 30, 2022 | 11.63M | -7.22M | -38.32% |
| Jun 30, 2021 | 18.85M | 13.06M | 225.25% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PolyNovo | 128.70M |
| SomnoMed | 111.49M |
| Aroa Biosurgery | 79.26M |
| Compumedics | 51.04M |
| Nova Eye Medical | 29.27M |
| CleanSpace Holdings | 19.76M |
| Micro-X | 13.05M |
| EMVision Medical Devices | 5.05M |